R. Janet Whitmore - 23 Sep 2024 Form 4 Insider Report for NANOPHASE TECHNOLOGIES Corp (SLSN)

Role
Director
Signature
/s/ Jess Jankowski under UPA for R. Janet Whitmore
Issuer symbol
SLSN
Transactions as of
23 Sep 2024
Net transactions value
+$79,550
Form type
4
Filing time
25 Sep 2024, 16:00:04 UTC
Previous filing
23 Sep 2024
Next filing
05 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NANX Common Stock Purchase $41,340 +26,000 +1.3% $1.59 1,979,909 23 Sep 2024 Direct F1
transaction NANX Common Stock Purchase $37,040 +23,150 +1.2% $1.60 2,003,059 24 Sep 2024 Direct F2
transaction NANX Common Stock Purchase $318 +200 +0.01% $1.59 2,003,259 24 Sep 2024 Direct
transaction NANX Common Stock Purchase $852 +550 +0.03% $1.55 2,003,809 24 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NANX Deferred Common Stock 20,030 23 Sep 2024 Common Stock 20,030 Direct F3, F4, F5
holding NANX Common Stock (right to purchase) 2,000 23 Sep 2024 Common Stock 2,000 $0.9000 Direct F6
holding NANX Common Stock (right to purchase) 2,000 23 Sep 2024 Common Stock 2,000 $1.05 Direct F6
holding NANX Common Stock (right to purchase) 2,000 23 Sep 2024 Common Stock 2,000 $1.18 Direct F6
holding NANX Common Stock (right to purchase) 2,000 23 Sep 2024 Common Stock 2,000 $0.8400 Direct F6
holding NANX Common Stock (right to purchase) 2,000 23 Sep 2024 Common Stock 2,000 $1.85 Direct F6
holding NANX Common Stock (right to purchase) 2,000 23 Sep 2024 Common Stock 2,000 $1.10 Direct F6
holding NANX Common Stock (right to purchase) 2,000 23 Sep 2024 Common Stock 2,000 $0.9900 Direct F6
holding NANX Common Stock (right to purchase) 10,000 23 Sep 2024 Common Stock 10,000 $0.6800 Direct F7
holding NANX Common Stock (right to purchase) 10,000 23 Sep 2024 Common Stock 10,000 $0.8200 Direct F7
holding NANX Common Stock (right to purchase) 6,667 23 Sep 2024 Common Stock 6,667 $0.4500 Direct F7
holding NANX Common Stock (right to purchase) 20,000 23 Sep 2024 Common Stock 20,000 $4.17 Direct F7
holding NANX Common Stock (right to purchase) 20,000 23 Sep 2024 Common Stock 20,000 $1.16 Direct F7
holding NANX Common Stock (right to purchase) 12,600 23 Sep 2024 Common Stock 12,600 $0.6100 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase of these 26,000 shares was made through 10 trades, all at $1.59/share. The trades were made throughout the day, with the smallest purchases (3 different transactions) being 100 shares and the largest being 6,000 shares. The average purchased amount among these transactions was 2,600 shares.
F2 The purchase of these 23,150 shares was made through 3 trades, all at $1.60/share. The trades amounted to 3,000, 20,050, and 100 shares, respectively.
F3 Each share of deferred common stock represents the right to receive one share of common stock.
F4 The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F5 Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan.
F6 The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. Two-thousand shares were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85. 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.
F7 Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.